ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Immunity, Cellular

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Biological Phenomena, Cell Phenomena, and Immunity ∟ Immunity ∟ Immunity, Cellular 29 coordinate concepts 4 subordinate concepts ∟ Antigen Presentation \| ∟ Immunologic Surveillance \| ∟ Lymphocyte Activation \| ∟ Transplantation Immunology ∟ Antibody Diversity \| ∟ Antibody Formation \| ∟ Antibody Specificity \| ∟ Antibody-Dependent Enhancement \| ∟ Antigen-Antibody Reactions \| ∟ Autoimmunity \| ∟ CD4-CD8 Ratio \| ∟ Complement Activation \| ∟ Cross-Priming \| ∟ Cytotoxicity, Immunologic \| ∟ Dose-Response Relationship, Immunologic \| ∟ Histamine Release \| ∟ HIV Seronegativity \| ∟ Immune Tolerance \| ∟ Immunity, Active \| ∟ Immunity, Herd \| ∟ Immunity, Maternally-Acquired \| ∟ Immunity, Mucosal \| ∟ Immunity, Natural \| ∟ Immunocompetence \| ∟ Immunocompromised Host \| ∟ Immunogenetics \| ∟ Immunologic Memory \| ∟ Lymphocyte Cooperation \| ∟ Neuroimmunomodulation \| ∟ Neutrophil Activation \| ∟ Neutrophil Infiltration \| ∟ T-Cell Antigen Receptor Specificity \| ∟ Tumor Escape X
Broader terms:	Medical Subject Headings (MeSH) ∟ Biological Phenomena, Cell Phenomena, and Immunity ∟ Immunity ∟ Immunity, Cellular Immunity > Biological Phenomena, Cell Phenomena, and Immunity > Medical Subject Headings (MeSH) X
Narrower terms:	Antigen Presentation \| Immunologic Surveillance \| Lymphocyte Activation \| Transplantation Immunology X
Annotation:	IM general only, NIM with specific disease /immunol (IM): TN 242 X
History note:	Immunity (1966-1969)X
historyNote*:	72(70) X
publicMeSHNote*:	72 X
Scope note:	Those manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. X
activeMeSHYear*:	1993 \| 1994 \| 1995 \| 1996 \| 1997 \| 1998 \| 1999 \| 2000 \| 2001 \| 2002 \| 2003 \| 2004 \| 2005 \| 2006 \| 2007X
dateCreated*:	1999-01-01X
dateEstablished*:	1972-01-01X
dateRevised*:	1992-05-14X
recordAuthorizer*:	PLSX
recordMaintainer*:	PLSX
recordOriginator*:	NLMX
Related term:	Hypersensitivity, Delayed X
Type:	Concept X
Coordinate terms:	Antibody Diversity \| Antibody Formation \| Antibody Specificity \| Antibody-Dependent Enhancement \| Antigen-Antibody Reactions \| Autoimmunity \| CD4-CD8 Ratio \| Complement Activation \| Cross-Priming \| Cytotoxicity, Immunologic \| Dose-Response Relationship, Immunologic \| Histamine Release \| HIV Seronegativity \| Immune Tolerance \| Immunity, Active \| Immunity, Herd \| Immunity, Maternally-Acquired \| Immunity, Mucosal \| Immunity, Natural \| Immunocompetence \| Immunocompromised Host \| Immunogenetics \| Immunologic Memory \| Lymphocyte Cooperation \| Neuroimmunomodulation \| Neutrophil Activation \| Neutrophil Infiltration \| T-Cell Antigen Receptor Specificity \| Tumor Escape X
URI:	X
Labels and equivalent concepts:	Soluvälitteinen immuniteetti (fi) CMI (fi, replaced) Immunitet, cellulär (sv) Cellförmedlad immunitet (sv, replaced) Cell-Mediated Immunity (en, replaced) X
Share:	X